Altamira Therapeutics Ltd. Made Headway
Wed, Dec 06, 2023 at 07:41 PM
Altamira Therapeutics Ltd. (CYTO:NASDAQ) shot up at $0.56, representing a gain of 54.7%. The stock got featured on our News Catalysts scanner on Tue, Dec 05, 2023 at 02:53 PM in the 'MISCELLANEOUS' category. From Fri, Nov 24, 2023, the stock recorded 50.00% Up Days and 44.44% Green Days
The stock spiked on Thu, Nov 30, 2023 at $0.86 with a volume of 69M+.
About Altamira Therapeutics Ltd. (CYTO:NASDAQ)
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders.
Top 10 Gainers:
- Kubient Inc. (KBNT:NASDAQ), 2757.14%
- MicroAlgo Inc. (MLGO:NASDAQ), 295.87%
- Sera Prognostics Inc. (SERA:NASDAQ), 153%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 150%
- SRAX, Inc. (SRAX:NASDAQ), 100%
- Signature Bank (SBNY:NASDAQ), 80%
- Altamira Therapeutics Ltd. (CYTO:NASDAQ), 54.7%
- Leju Holdings Limited (LEJU:NYSE), 51.57%
- Troika Media Group Inc. (TRKA:NASDAQ), 44.7%
- Pineapple Financial Inc. (PAPL:NYSEMKT), 43.29%